HHV-1 HHV-2
Molecule No Ligand Efficiency Binding Affinity (kcal/mol) Inhibitory Constant mM Molecule No Ligand Efficiency Binding Affinity (kcal/mol) Inhibitory Constant mM
1. -0.12 -1.12 151.26 1. -0.09 -1.08 357.89
2.* -0.31 -5.17 162.74 μM 2. -0.12 -0.6 283.12
3. -0.14 -1.27 117.75 3. -0.25 -2.23 23.11
5. -0.09 -2.03 32.6 5. -0.19 -4.16 891.05 μM
8. -0.24 -2.68 10.94 8. -0.34 -3.73 1.85
9. -0.11 -1.02 179.96 9. -0.29 -4.68 374.07 μM
10. -0.13 -4.15 911.93 μM 10. -0.18 -5.45 100.59 μM
11. -0.19 -2.25 22.31 11. -0.22 -2.69 10.68
12. -0.07 -1.6 67.57 12. -0.11 -2.37 18.21
14. -0.26 -3.67 1.53 14.** -0.41 -6.31 23.85 μM
15. -0.17 -2.79 8.97 15. -0.31 -4.9 255.87 μM
16. -0.15 -4.17 874.94 μM 16. -0.15 -4.27 740.21 μM
18. -0.08 -1.53 76.18 18. -0.18 -3.67 2.03
19. -0.26 -3.88 1.42 19. -0.34 -5.17 161.72 μM
21. -0.01 -0.36 545.97 21. -0.11 -4.27 743.19 μM
*,** Similar Results
Table 6: Docking results of screened Natural Antiviral compounds with HHV-1 and HHV-2 of Glycoprotein.
Goto home»